Call Us: (1) 608 441-2729 - Email Us firstname.lastname@example.org
M2SR: The Vaccine
Board of Directors
Clinical Advisory Board
News and opinions
Flugen founder Dr. Yoshiro Kawaoka will recieve Japanese Medal of Honor with a Purple Ribbon from the Japanese Emperor
September 27, 2011
Share this Story
Comments are closed.
Watch FluGen President & CEO Paul Radspinner speak at the Jefferies 2021 Virtual Healthcare Conference
FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85
UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine
Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice
FluGen’s M2SR Phase 2 Human Challenge Trial Initial Results
(c)2016 FluGen, Inc. All rights reserved.
Back to Top